We are live on ! Find out more
CMIIU

CM Life Sciences II Inc. Unit

Delisted

CMIIU was delisted on the 1st of September, 2021.

58 hedge funds and large institutions have $290M invested in CM Life Sciences II Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+58
Holders Change %
% of All Funds
1.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
58
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SC
51
Shay Capital
New York
$256K +$251K +20,000 New
WAM
52
Wolverine Asset Management
Illinois
$241K +$237K +18,885 New
AA
53
AQR Arbitrage
Connecticut
$128K +$126K +10,000 New
Wells Fargo
54
Wells Fargo
California
$77K +$75.3K +6,000 New
Bank of America
55
Bank of America
North Carolina
$51K +$50.2K +4,000 New
UBS Group
56
UBS Group
Switzerland
$48K +$46.9K +3,735 New
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
$38K +$37.7K +3,000 New
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
+$126 +10 New

CMIIU Hedge Fund Activity: Q1 2021 in Review

58 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q1 2021, worth a combined $290M.

Buyers outnumbered sellers: 58 funds opened new CMIIU positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SB Management, opening a new position worth an estimated $34.3M.

  • 58 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $290M of CM Life Sciences II Inc. Unit stock for Q1 2021.
  • 58 funds opened new CM Life Sciences II Inc. Unit positions in Q1 2021 and 0 closed out, a net change of +58 holders.
  • The largest CM Life Sciences II Inc. Unit buyer in Q1 2021 was SB Management, an estimated $34.3M added.

Based on aggregated 13F filings for Q1 2021.